An Exclusive Interview with Scott Decker, President and CEO of Healthvision
posted 02/16/2007
HIStalk
Right after New Year's, I published reader-provided speculation that
security and Internet giant VeriSign would be making an investment in
Irving, TX-based Healthvision. Healthvision CEO Scott Decker sent me a
nice e-mail, saying that he had followed HIStalk for six months and was
"glad to see you are closing in on the actual story."
He explained that VeriSign would be making a minority investment, not
an outright purchase, concluding with "Your blog has forced me to start
talking to clients this week before the press releases have all been
approved, so this is generally market information that should be
‘official’ later this week ... If you think your
readers would be interested, I would be happy to spin through one of
your interviews and give you my perspective on the world of Connected
Healthcare Communities."
We had to work around our respective schedules, so by chance, both the
official announcement and the interview occurred today. Thanks to Scott
for taking time on what I'm sure was a hectic day to spend some time
with HIStalk.
Tell me about
Healthvision.
The company was formed in 1999. We have about 100 employees, probably
about 110 now. We’re still a private company. The business
we’re in is building connected healthcare communities, which
is how you connect the fragrmented healthcare system
and get the right information to the right people at right time. We do
it as an ASP, so we’ve built a web-based
infrastructure. We have about 41,000 clinical users as subscribers who
get access to clinical information through our system.
Here are two examples of what we do. Let's say I'm a primary care
provider who's on Medicalogic and the guy down street uses
Allscripts.
We have a mechanism to keep using your system and sharing your data
with
the Allscripts guy and vice versa. Maybe it's the doctor in the office
next
to you. We're taking the pain away from moving data.
Ultimately,
we're going to win when, in the Dallas-Fort Worth area, I can get on a
site called scottdecker.myhealth.com or something like that and pull up
a screen that looks like My Yahoo with my information,
which came from
a hospital, four or five
physicians, and payors. All those things coming to me. In the markets
we’re
in, we’re pretty darned close. Where we aren’t,
we’re not even close.
That’s what we’re about – facilitating
those kinds of things.
What is the nature of
VeriSign's investment and their interest in Healthvision and the
healthcare industry?
It’s been a really interesting deal for us. They spent a year
talking to us, as well as quite a few other people in the healthcare
industry.
From a corporate standpoint, VeriSign has two core businesses.
They resolve all .com and .net DNS addresses, supporting 25 billion
queries a day. Most people are familiar with their checkmark asset.
They put in security infrastructures for 95% of the Fortune
500. Third, they do SMS message switching for telcoms, so if you send a
text message from Cingular to Sprint, they handle it through
their brokering hub, 150 million times a day.
VeriSign is looking for partners to use those technologies.
They tried to find the right partner to get into healthcare. Because of
our Internet network based model and our approach to the market, they
saw synergies. They could apply their asset to healthcare. For us,
it’s a great partner and infrastructure that tackles problems
like scale, trust, and security.
What VeriSign security
technologies make sense for Healthvision customers?
We can bolt their messaging to our networks easily. I should mention
that they can transform that message to reformat it for Blackberry,
Palm, or any device in a secured fashion. The second technology
we’re excited about is their security front-end, which they
call their fraud and abuse and person verification front end.
HealthVision seems to
have changed its business model a few times, from hospital web pages,
then portals, and now interoperability. Are you chasing fads or
responding to market opportunities?
It’s interesting to hear that perspective because
we’ve always been about providing a centralized portal
toolkit. From day one, we’ve helped hospitals with that
infrastructure; with consumer websites, which few hospitals had in 1999
when we started; and web or portal technology to get clinical
information out to end users, primarily physicians and their office
staff. We started building that infrastructure in 1999. Certainly
we’ve switched our marketing to match where
people’s interest lies, so it may seem we’ve been
switching focus, but it’s been the same platform the whole
time.
When proposed the Neoforma merger
with Eclipsys and Healthvision failed in 2000, Healthvision
was supposedly worth $2 billion. Did the dot-com bust hit hard?
It was real hard for us, just like for everybody else who went through
it. I don't know if it was $2 billion, but we were saying $1
billion. It was a bizarre time.
The good news is that we were building products and planning, even when
we were playing all the same games as everyone else with free money. On
the bad side, we didn't go public, so we didn’t get that cash
in the door. We built a traditional technology company post-meltdown.
Mindsets changed. It was a tough transition, but we made it through it
and we still have 98% of the customers we had them. Certainly
it’s easier to manage the business today when it’s
about what works and how cash works.
General Atlantic expected
synergies between Healthvision and Eclipsys. Did it get them?
No. I don’t think anyone who didn’t cash out got
the synergies they were dreaming about. Everybody was trying to
capitalize on anything dot-com. Eclipsys spun out their
Internet assets just to get capital. Of the companies General Atlantic
Partners invested in at that time, probably 50 or 60% of the dotcoms
went away, but at least they got a viable company out of it.
Thankfully, we’re past those days.
Who are your competitors
and why do you think Healthvision’s products are better than
theirs?
It’s changed over the years. For 2007, MedSeek, Medicity,
Axolotl, and Wellogic on one side of the equation. We’re also
competing against IBM and CSC and other large integrators.
What differentiates us is that we truly are an ASP company and
that’s how we operate. Some folks sell a toolkit and
it’s up to you to figure out how to use it. We offer
a managed service. We're not saying it's the only way, but it gives a
good option for potential clients to look at.
The other thing that’s different is experience, especially
running domains of healthcare communities. We're in 20 markets with 100
to 150 hospitals, so from an experience standpoint, there
aren’t many people working a network-based RHIO connected
community with that experience. We have eight years of experience in
developing and improving our infrastructure.
To what extent will RHIOs
succeed?
They’re gaining traction. It’s exciting because
there are so many. Even three years ago, there were only a couple of
dozen. Now there are 250. It’s an experiment. Some will work,
some won't. They're doing OK. They're probably moving as fast as
anything can move in healthcare, especially for something
that’s as dramatic of a paradigm shift.
Are Healthvision's
fortunes tied to theirs?
I wouldn’t say Healthvision is wed to RHIOs, but to
disparate groups sharing information. RHIOs brought it back up to the
attention of boards and providers. We see all kinds of hybrids
– health systems, IPAs, payors. There are a lot of RHIO-like
models that aren’t the Washington, DC model, and that's good
for us and good for healthcare. Our pipeline of opportunity is ten
times what it was 24 months ago.
What do you think of the
work being done on a national health information network and the
companies that are doing it?
We’re involved in one of those, with IBM's bid because of our
work with Taconic. NHIN is interesting because they've proven some
interoperability, but the reality is that we have lots and lots of work
to do at the community level to get the infrastructure in place before
we connect communities together.
I’d rather see the energy put into local projects without
worrying about national ones. I don’t see much there that
will help our clients. I like the state of New York model instead of NHIN,
where they’ve taken a few hundred million dollars and
allocated it to communities that have a business plan and matching
dollars and can get problems solved locally.
There’s a theoretical view of RHIOs with HIMSS and
all that, then there's the practical people building the networks at
the ground level. There's not a lot of cross-pollination. There are
things Healthvision can do at the national level and will pursue with
VeriSign.
The biggest pain point is still the cost of integrating legacy systems,
especially for outpatients. Right now, that still involves building a
point-to-point pipe, and even if you can get hub technology, it
won’t work economically. The SureScript model is a good
model. We can get some consolidation of integration done. Maybe all
Allscripts users can connect into a hub and other vendors get a single
point of contact so we don’t have to do point-to-point
interfaces. I think that’s where you might see some
cross-pollination of concepts.
So is the cost of moving
from RHIOs to NHIN worth it?
I don’t see it as a transformation. Over time, hopefully
we’ll have overlay technologies that will allow connecting
regional exchanges together. I think the cost is overestimated.
How would you assess the
personal health records market?
It’s neat. It’s where it has to go over time for us
to push forward, but it's nascent, like Quicken 1985. If you want to do
your checkbook online and track it with your spreadsheet and not your
checkbook, that’s what a PHR is now. Until they’re
connected to your bank and broker and other things, you won’t
see them take off. The question is when
we’ll connect them to clinical data. Like financial
records, you want to share some of it with financial partners, and I
can see PHRs going the same path.
Does anyone have any new
PHR ideas?
Everybody I talk to agrees it’s not a hard application, just
a different front end. It’s not all that sophisticated.
It’s just the back-end connectivity that's hard. I've heard
rumblings that Google and Microsoft are getting into it shortly, so the
game could change quickly. There’s been no money put
into development so far. If someone makes a business case or
sells ad views, do the math. With 150 million American using it, even
at a small annual fee, it’s big dollars.
What are you looking
forward to at HIMSS?
Just having a lot of conversations with more of the vendor side of the
world to see how far we’re getting along in sharing
information seamlessly. We’ve worked with vendors on EMR
interoperability for the past year, to be able to share information
regardless of whose EMR it is. It’s a cultural and mind
shift. It will be a good benchmark to go to HIMSS and see where we are,
and also to see the response we get from the VeriSign announcement.
Who do you admire in the
industry?
I admire the folks who are trying to do something different. Next year
will be my 20th anniversary in the HIT world. If I step back, it can be
frustrating compared to how the technology has changed around it. Pat
Cline at NextGen and Glenn Tullman at Allscripts, who
stuck with the technology. Like other guys coming up with new models of
computing, athenahealth and eClinical Works. They're trying to
get us to a network-based system and the economies of scale for our
industry are huge.
You’ve got to admire the people who work in the industry and
deal with all this fragmentation and messed up incentives. Once you get
into it and gain a passion for it, you won't get out of it, for better or
for worse, so there’s probably a mutual appreciation society
as we work through it together.
Do you read HIStalk?
I sure do. Several of my clients, probably a year ago, started saying,
"You gotta look at this thing." It's pretty entertaining. It's hard as
a CEO to see unfiltered data and HIStalk really does a great job of
getting that unfiltered dialog going. It's rough around the edges at
times, but for the value it brings, it's really pretty cool.